Logo

Breast Cancer

News and reporting on breast cancer.

Brain Metastases Analysis Points to Distinct Tumor Immune Microenvironments, Potential Treatments

Researchers conducted an immunogenomic analysis of brain metastases from individuals with primary lung or breast cancer.

Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses

Immune-related gene expression signatures tracked more closely with treatment response and outcomes than tumor-infiltrating lymphocytes in early-stage HER2-positive breast cancer.

Gene Expression Score IDs Breast Cancer Patients Responsive to Histone Deacetylase 6 Inhibitor
Premium

The gene activity signature could serve as a predictive biomarker for HDAC6 inhibitor response among metastatic breast cancer patients.

Guardant Health, Susan G. Komen Partner to Evaluate MRD Test in Breast Cancer

The test is designed to detect circulating tumor DNA in early-stage cancer patients after surgery to help oncologists identify those with residual or recurring disease.

Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK

BSPS will provide cancer sequencing services using two cancer gene panels currently under development at Everything Genetic to customers across the UK.

Dec 14, 2022

Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round

Dec 14, 2022

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform

Dec 12, 2022

NeoGenomics Growing Evidence Base for Residual Disease Assay in Breast Cancer
Premium

Dec 12, 2022

Myriad Genetics Generates More Data on its PRS's Ability to Identify Who Will Develop Breast Cancer
Premium

Dec 9, 2022

Exact Sciences Takes Aim at Radiotherapy Response Prediction With New Gene Expression Data
Premium

Dec 9, 2022

Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug

Dec 7, 2022

Intermountain Builds Up Bioinformatics to Make HerediGene Sequencing Data Clinically Actionable
Premium

Nov 29, 2022

Breast Cancer Genomic Recurrence Signature Influenced by BMI in Young Patients

Nov 28, 2022

Halo Diagnostics, Ikonopedia Partner to Provide Genetic Testing for Breast Cancer

Nov 9, 2022

Spatial Molecular Microscopy Enables Mapping of Breast Cancer Clones

Oct 28, 2022

Cell-Free DNA Methylome Signatures Show Potential for Early Cancer Detection
Premium

Oct 17, 2022

Polygenic Risk Scores Could Refine Breast Cancer Screening Recommendations
Premium

Oct 12, 2022

Angle Signs Distribution Deal for Parsortix Cell Sorting System in Czech Republic

Oct 11, 2022

South Korean Proteomics Firm Bertis Opening CLIA Lab in San Diego by End of Year
Premium

Oct 6, 2022

Breast Cancer Risk Contributors, Remaining Gaps Found With Familial Analyses

Sep 7, 2022

Matched Therapy 'Evidence Scale' Predicts Targeted Treatment Efficacy in Breast Cancer Patients

Aug 5, 2022

Polygenic Risk Score Firm Antegenes Aims to Invest in International Expansion, R&D
Premium

Aug 4, 2022

PTEN Mutation Syndrome Leads to Breast Cancers With Distinct Molecular Alterations

Aug 3, 2022

Exact Sciences Partners With West German Study Group to Validate MRD Test in Breast Cancer

Aug 2, 2022

Envisagenics Wins $2M SBIR Grant From NCI for Splicing-Based Immunotherapy Target Discovery Platform

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.